| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:08:02 -0700 |
| HMDB ID |
HMDB00186 |
| Secondary Accession Numbers |
|
| Metabolite Identification |
| Common Name |
Alpha-Lactose |
| Description |
alpha-Lactose is the major sugar present in milk and the main source of energy supplied to the newborn mammalian in its mother's milk. Lactose is also an important osmotic regulator of lactation. It is digested by the intestinal lactase (EC 3.2.1.108), an enzyme expressed in newborns. Its activity declines following weaning. As a result, adult mammals are normally lactose-intolerant and more than 75% of the human adult population suffers from lactase deficiency. Lactase deficiency is present in up to 80 percent of blacks and Latinos, and up to 100 percent of American Indians and Asians. Persons with lactose intolerance are unable to digest significant amounts of lactose. Common symptoms include abdominal pain and bloating, excessive flatus, and watery stool following the ingestion of foods containing lactose. A sizable number of adults believe they are lactose intolerant but do not actually have impaired lactose digestion, and some persons with lactase deficiency can tolerate moderate amounts of ingested lactose. A diagnosis of lactose intolerance can usually be made with a careful history supported by dietary manipulation. If necessary, diagnosis can be confirmed by using a breath hydrogen or lactose tolerance test. These mostly uncomfortable symptoms of lactose maldigestion are blamed for a variably dairy consumption. There is, however, emerging evidence that certain lactic acid-producing bacteria, which selectively consume prebiotics, may be beneficial against some lower intestinal diseases. Lactose maldigestion and lactose should perhaps be re-evaluated as a potential provider of such a prebiotic. Treatment consists primarily of avoiding lactose-containing foods. Lactase enzyme supplements may be helpful. The degree of lactose malabsorption varies greatly among patients with lactose intolerance, but most of them can ingest up to 350 mL of milk daily without symptoms. Lactose-intolerant patients must ensure adequate calcium intake. (PMID: 13130292 , 12216958 , 12197838 , 12018807 ). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- (+)-lactose
- 1-beta-D-Galactopyranosyl-4-alpha-D-glucopyranose
- 1-beta-delta-Galactopyranosyl-4-alpha-delta-glucopyranose
- 4-O-Hexopyranosylhexose
- a-Lactose
- Aletobiose
- alpha-Lactose
- Anhydrous lactose
- Dilactose
- Fast-Flo Lactose
- Flowlac 100
- Galactinum
- Glc-(4-1)Gal
- Granulac 140M
- Lactin
- Lactin (carbohydrate)
- Lactobiose
- Lactohale 300
- Lactose
- Lactose anhydride
- Lactose Fast-flo
- Milk sugar
- Osmolactan
- Pharmatosa DCL 21
- Pharmatose 21
- Pharmatose 325M
- Pharmatose DCL 15
- Prismalac
- Respitose ML 003
- Respitose SV 003
- Saccharum lactin
- Sachelac
- Sorbalac 400
- Sorbolac 400
- Spherolac
- Super-Tab
- Tablettose
- Tablettose 70
- Tablettose 80
- Zeparox EP
|
| Chemical Formula |
C12H22O11 |
| Average Molecular Weight |
342.2965 |
| Monoisotopic Molecular Weight |
342.116211546 |
| IUPAC Name |
(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-{[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxane-3,4,5-triol |
| Traditional IUPAC Name |
α-lactose |
| CAS Registry Number |
63-42-3 |
| SMILES |
OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O |
| InChI Identifier |
InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5+,6+,7-,8-,9-,10-,11+,12+/m1/s1 |
| InChI Key |
GUBGYTABKSRVRQ-XLOQQCSPSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Carbohydrates and Carbohydrate Conjugates |
| Class |
Disaccharides |
| Sub Class |
Dihexoses |
| Other Descriptors |
- Aliphatic Heteropolycyclic Compounds
- lactose(ChEBI)
|
| Substituents |
- 1,2 Diol
- Acetal
- Glycosyl Compound
- Hemiacetal
- O Glycosyl Compound
- Oxane
- Primary Alcohol
- Secondary Alcohol
|
| Direct Parent |
Dihexoses |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Component of Galactose metabolism
- Component of Glycerolipid metabolism
- Component of Glycosphingolipid metabolism
- Component of Keratan sulfate biosynthesis
- Component of N-Glycan biosynthesis
|
| Application |
Not Available |
| Cellular locations |
- Cytoplasm
- Extracellular
- Lysosome
- Golgi apparatus
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
201 - 202 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
195 mg/mL at 20 °C |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
|
| Biological Properties |
| Cellular Locations |
- Cytoplasm
- Extracellular
- Lysosome
- Golgi apparatus
|
| Biofluid Locations |
|
| Tissue Location |
- Muscle
- Bladder
- Intestine
- Skin
- Platelet
- Gut
- Spleen
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Normal |
Inferred from detection in urine
|
| Urine |
Detected and Quantified |
|
11.8 (1.0-24.2) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
by NMR
|
| Urine |
Detected and Quantified |
|
30.0 (13.0-49.0) umol/mmol creatinine |
Infant (0-1 year old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
1.45 (0.63-3.45) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
6.08 +/- 6.07 umol/mmol creatinine |
Infant (0-1 year old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
Not Available |
| Associated Disorders and Diseases |
| Disease References |
None |
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
DB04465  |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB001145 |
| KNApSAcK ID |
C00001136  |
| Chemspider ID |
76293  |
| KEGG Compound ID |
C00243  |
| BioCyc ID |
LACTOSE  |
| BiGG ID |
34366  |
| Wikipedia Link |
Lactose  |
| NuGOwiki Link |
HMDB00186  |
| Metagene Link |
HMDB00186  |
| METLIN ID |
267  |
| PubChem Compound |
84571  |
| PDB ID |
LBT  |
| ChEBI ID |
36219  |
| References |
| Synthesis Reference |
Ruffing, Anne; Mao, Zichao; Ruizhen Chen, Rachel. Metabolic engineering of Agrobacterium sp. for UDP-galactose regeneration and oligosaccharide synthesis. Metabolic Engineering (2006), 8(5), 465-473. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Jung SK, Fujimoto D: A novel beta-galactoside-binding lectin in adult rat kidney. J Biochem (Tokyo). 1994 Sep;116(3):547-53.
Pubmed: 7852273
- Oozeer R, Furet JP, Goupil-Feuillerat N, Anba J, Mengaud J, Corthier G: Differential activities of four Lactobacillus casei promoters during bacterial transit through the gastrointestinal tracts of human-microbiota-associated mice. Appl Environ Microbiol. 2005 Mar;71(3):1356-63.
Pubmed: 15746338
- Dimopoulos MA, Anagnostopoulos A: Thalidomide in relapsed/refractory multiple myeloma: pivotal trials conducted outside the United States. Semin Hematol. 2003 Oct;40(4 Suppl 4):8-16.
Pubmed: 15015891
- Muthusamy A, Erickson DR, Sheykhnazari M, Bhavanandan VP: Enhanced binding of modified pentosan polysulfate and heparin to bladder--a strategy for improved treatment of interstitial cystitis. Urology. 2006 Jan;67(1):209-13.
Pubmed: 16413377
- Johnson JD, Simoons FJ, Hurwitz R, Grange A, Mitchell CH, Sinatra FR, Sunshine P, Robertson WV, Bennett PH, Kretchmer N: Lactose malabsorption among the Pima indians of Arizona. Gastroenterology. 1977 Dec;73(6):1299-304.
Pubmed: 578795
- Lustenberger RW: [A 23-year old patient with chronic diarrhea. Celiac disease and lactose intolerance] Schweiz Rundsch Med Prax. 2005 Feb 2;94(5):163-4.
Pubmed: 15745382
- Sharma A, DiCioccio RA, Allen HJ: Identification and synthesis of a novel 15 kDa beta-galactoside-binding lectin in human leukocytes. Glycobiology. 1992 Aug;2(4):285-92.
Pubmed: 1421750
- Rana SV, Bhasin DK, Vinayak VK: Lactose hydrogen breath test in Giardia lamblia-positive patients. Dig Dis Sci. 2005 Feb;50(2):259-61.
Pubmed: 15745082
- Mitchell JD, Brand J, Halbisch J: Weight-gain inhibition by lactose in Australian Aboriginal children. A controlled trial of normal and lactose hydrolysed milk. Lancet. 1977 Mar 5;1(8010):500-2.
Pubmed: 65606
- Soupene E, van Heeswijk WC, Plumbridge J, Stewart V, Bertenthal D, Lee H, Prasad G, Paliy O, Charernnoppakul P, Kustu S: Physiological studies of Escherichia coli strain MG1655: growth defects and apparent cross-regulation of gene expression. J Bacteriol. 2003 Sep;185(18):5611-26.
Pubmed: 12949114
- Yeoh E, Horowitz M, Russo A, Muecke T, Robb T, Chatterton B: The effects of abdominal irradiation for seminoma of the testis on gastrointestinal function. J Gastroenterol Hepatol. 1995 Mar-Apr;10(2):125-30.
Pubmed: 7787155
- Bondesson E, Bengtsson T, Borgstrom L, Nilsson LE, Norrgren K, Olsson B, Svensson M, Wollmer P: Dose delivery late in the breath can increase dry powder aerosol penetration into the lungs. J Aerosol Med. 2005 Spring;18(1):23-33.
Pubmed: 15741771
- Roberson CM: Lactose intolerance. Ala Nurse. 2004 Dec-2005 Feb;31(4):23-4; quiz 24.
Pubmed: 15662762
- Kim KI, Lee WS, Benevenga NJ: Feeding diets containing high levels of milk products or cellulose decrease urease activity and ammonia production in rat intestine. J Nutr. 1998 Jul;128(7):1186-91.
Pubmed: 9649604
- Gunther S, Patterson RE, Kristal AR, Stratton KL, White E: Demographic and health-related correlates of herbal and specialty supplement use. J Am Diet Assoc. 2004 Jan;104(1):27-34.
Pubmed: 14702580
|